Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.8401 (1.22%) ($0.8401 - $0.8401) on Wed. Feb. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.18% (three month average) | RSI | 33 | Latest Price | $0.8401(1.22%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -20.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PCY(35%) EWI(27%) EWG(22%) DRIV(21%) QQQ(21%) | Factors Impacting ANPC price | ANPC will decline at least -3.59% in a week (0% probabilities). VIXM(-31%) USO(-21%) TIP(-20%) BNDX(-20%) SHY(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.59% (StdDev 7.18%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-29.94(-3663.86%) | Resistance Level | $1.04 | 5 Day Moving Average | $0.78(7.71%) | 10 Day Moving Average | $0.87(-3.44%) | 20 Day Moving Average | $1.04(-19.22%) | To recent high | -67.9% | To recent low | 16.7% | Market Cap | $7m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |